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Abstract
Askin’s tumour is a primitive neuroectodermal tumour developing from the soft tissues of the chest wall. It is commonly 
misdiagnosed due to features similar to other round blue cell tumours. The approach for its diagnosis and treatment 
is complex and requires a multidisciplinary team. The recommended treatment is chemotherapy and surgical excision 
mainly. The prognosis is dependent on many factors. We managed a child of Askin’s tumour using modalities such as 
neoadjuvant chemotherapy and surgical excision and found a good response.
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Introduction
Literature showed that frequency of Ewing’s sarcoma (ES) 
and primitive neuroectodermal tumours (PNETs) among 
childhood tumours is just 2%. That is the reason during the 
age of infancy and childhood, ESs and PNETs considered 
to be very rare.[1] Askin’s tumour in childhood usually 
presents with common symptoms of upper respiratory tract 
infections. These are closely related neoplasms derived 
from the neural crest cells tumours.[2] In 1979, Askin et al. 
separated PNETs originating from thoracopulmonary 
region and named Askin’s tumour. They belong to the 
family of the small round blue cell tumours and have 
no specific clinical and pathologic features which make 
difficult to differentiate it from other tumours of their 
family.[3] In general, prognosis of these tumours is poor. 
The index case showed good response to multimodality 
treatment and till now no signs and symptoms of 
recurrence. Furthermore, on searching literature, we found 
that to date, there are very few case reports from Pakistan.
Case Report
A 7-year-old boy presented to the oncology department 
with complaint of intermittent, dull and moderate-to-
severe pain along with progressively increasing swelling 
on the left lower chest wall for 1 year.
Patient was initially managed as a case of pulmonary 
Tuberculosis for about 3 months with no response. On 
examination, there was about 20 cm × 14 cm firm, non-
tender and non-fluctuant swelling on the left chest wall 
extending from 5th to 9th rib [Figure 1]. All other physical 
parameters and laboratories including alpha-fetoprotein 
and beta-human chorionic gonadotropin were within 
normal range. Abdominal ultrasound showed complex 
multiloculated mild-to-moderate effusion involving 
lateral chest wall with internal septations and underlying 
consolidation. On CT scan, 19.3 cm × 12.7 cm sized 
cystic mass in the left hemithorax with displacement of 
mediastinum. The evidence of rib destruction was there, 
but there was no mediastinal lymphadenopathy or bone 
involvement [Figure 2]. An incisional biopsy of mass was 
done and proved out to be CD99-positive round blue cell 
tumour probably ES [Figure 3]. The patient underwent 
6 cycles of chemotherapy (vincristine, ifosfamide, 
doxorubicin and etoposide). Post-chemotherapy scan 
depicted reduction in mass size to just 6.0 cm × 2.6 cm 
located underneath the lower left ribs, inseparable from the 
left lateral hemidiaphragm involving inner lower chest and 
upper abdominal wall but no lung infiltration [Figure 4]. 
The case was discussed in tumour board; excision of 
tumour was planned. The left subcostal incision was 
made and tumour approached through transdiaphragmatic 
route as it was involving the underlying ribs and 
diaphragm. After opening the diaphragm, it was visible 
on undersurface of lower ribs and excision was done 
[Figures 5-7].
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Peroperatively tumour was 5 cm × 6 cm arising from the 
periosteum of lower ribs and attached to pleura of the 
left lower lobe and left hemidiaphragm. Periosteum was 
shaved and underlying rib surface was smooth. Biopsies 
were taken from pleural site, diaphragm and periosteum of 
rib. Closure of diaphragm and abdomen done [Figure 7]. 
Post-operative recovery of the patient was smooth and 
uneventful. He was initially shifted to intensive care unit 
and then general ward after 3 days. Chest tube was removed 
after 5 days. The patient was referred back to oncology 
ward. On histopathological examination of resected mass, 
there was no tumourous tissue and there was only fibrous 
tissue with necrosis. Furthermore, there was no residual 
tumour in pleura, diaphragm or rib periosteum. At 3 6 
and 9 months’ follow–up, the patient is doing fine and 
completed his post-operative chemotherapy.
Figure 1: Anterior chest and abdomen picture
Figure 2: CT chest with contrast. The left chest wall (blue arrow) 
mass displacing the mediastinum
Figure 4: Post-chemotherapy CT scan showed a significant 
reduction in the left chest tumour mass
Figure 5: Residual tumour seen along the inside of chest wall 
(black solid arrow)
Figure 3: Round blue cell tumour (H and E)
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Discussion
PNETs, a group of highly malignant tumours, are of 
neuroectodermal origin that affects mainly soft tissue and 
bone. Due to indistinguishable clinical and pathologic 
features, Batsakis et al. divided the PNET family of 
tumours into the following three groups: Central nervous 
system PNETs, autonomic nervous system PNETs 
(neuroblastoma) and peripheral PNETs (pPNETs).[4] The 
annual incidence of PNETs is 2.9 per million population 
with a slight male preponderance. Askin’s tumour also 
named as “extra skeletal ES” or “soft tissue ES” arising 
from the soft tissue of the chest wall and usually present 
in the second decade of life.[5] For extraosseous primary 
tumours, the most common primary sites of disease 
include the following: Trunk (32%), extremities (26%), 
head and neck (18%) and retroperitoneum (16%).[6]
Askin’s tumour may present as a solitary mass, rarely 
involving most of the hemithorax or as multiple masses 
in the thoracopulmonary region (thoracic wall, lung, 
mediastinum or pericardium). Mostly, these tumours 
show a neural differentiation that can be demonstrated 
by immune histochemical and ultrastructural methods. 
Similar to ES and PNET, regarding immunohistochemistry, 
these tumours show positivity for neural markers such as 
neuron-specific enolase, CD99 and vimentin including 
neuroendocrine markers, such as chromogranin and 
synaptophysin.[7]
CD 99 was also positive in our index case. In the thoracic 
area, these tumours are invasive and prone to involve bone 
(ribs and scapula), invading the retroperitoneal space 
and spreading to lymph nodes, adrenals, and liver[3] and 
usually present with common respiratory symptoms. In 
our case, lower ribs were also involved but responded 
to chemotherapy very well and no involvement was 
found peroperatively. Treatment is actually multimodal 
including chemotherapy, surgery and radiotherapy. 
Venkitaraman et al. proposed remarkable remission rate 
from 26% to 65% after chemotherapy. Most commonly 
used chemotherapy regimens include vincristine, 
actinomycin D and cyclophosphamide (VAC), VAC 
adriamycin (VACA) and VAC alternating IE (ifosfamide 
and etoposide).[8] The regimen used by our oncology team 
was vincristine, ifosfamide, doxorubicin and etoposide 
and the patient responded well. The next important role to 
improve survival is complete surgical excision of tumour, 
though approach needs modification regarding exact 
location of tumour. In this case, the surgeon approached 
the residual tumour through transdiaphragmatic route. 
The extension of the tumour at diagnosis is the factor 
affecting prognosis although 70% of 5-year survival is 
documented in literature.[9]
ES is usually sensitive to radiotherapy but needs to 
categorise the patient as far as selection is concerned, 
especially in case of younger age patient.[10]
No metastasis or relapse was seen in index case after 
successful excision and chemotherapy so radiotherapy 
was not given. The most common complications which 
can occur are in the form of relapses and musculoskeletal 
abnormalities, fortunately, both of which were not present 
in our case, as tumour proved out to be chemosensitive 
and great reduction in size was there which was easy to 
excise without any thoracic wall deformity.
Figure 6: Residual tumours excised (black arrow)
Figure 7: Repair of the diaphragm after excision of tumour 
(black arrow)
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Conclusion
Askin’s tumour is very rare in childhood. The most 
common presentation is with respiratory symptoms. High 
index of suspicion is required to diagnose it.
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